Growth hormone response to clonidine as a biological marker in psychiatric research – A review of the literature

References

• Muller E E. Neural control of somatotropic function. Physiol Rev 1987; 67: 962–1053
   PubMed Web of Science ®Google Scholar
• Lal S. Growth hormone and schizophrenia. Psychopharmacology. The Third Generation of Progress, H Y Meltzer. Raven Press, New York 1987; 809–18
   Google Scholar
• Monteleone P, Maj M, Iovino M, Steardo L. Growth hormone response to sodium valproate in chronic schizophrenia. Biol Psychiatry 1986; 21: 588–94
   PubMed Web of Science ®Google Scholar
• Lal S, Tolis G, Martin J B, Brown G M, Guyda H. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab 1975; 41: 827–32
   PubMed Web of Science ®Google Scholar
• Durand D, Martin J B, Brazeau P. Evidence for a role of alpha-adrenergic mechanisms in the regulation of episodic growth hormone secretion in the rat. Endocrinology 1977; 100: 722–8
   PubMed Web of Science ®Google Scholar
• Eden S, Modigh K. Effects of apomorphine and clonidine on rat plasma growth hormone after pre-treatment with reserpine and electroconvulsive shocks. Brain Res 1977; 129: 379–84
   PubMed Web of Science ®Google Scholar
• Eriksson E, Eden S, Modigh K. Up- and down-regulation of central postsynaptic alpha2-adrenoceptors reflected in the growth hormone response to clonidine in the reserpine-pretreated rat. Psychopharmacology 1982; 77: 327–31
   PubMed Web of Science ®Google Scholar
• Krulich L, Mayfield M A, Steele M K, McMillan B A, McCann S M, Koenig J I. Differential effects of pharmacological manipulations of central alpha1- and alpha2-adrenergic receptors on the secretion of thyrotropin and growth hormone in male rats. Endocrinology 1982; 110: 796–804
   PubMed Web of Science ®Google Scholar
• Kabayama Y, Kato Y, Murakami Y, Tanaka H, Imura H. Stimulation by alpha-adrenergic mechanisms of the secretion of growth hormone-releasing factor (GRF) from perifused rat hypothalamus. Endocrinology 1986; 119: 432–4
   PubMed Web of Science ®Google Scholar
• Eden S, Eriksson E, Martin J B, Modigh K. Evidence for a growth hormone releasing factor mediating alpha-adrenergic influence on growth hormone secretion in the rat. Neuroendocrinology 1981; 33: 24–7
   PubMed Web of Science ®Google Scholar
• Miki N, Ono M, Shizume K. Evidence that opiatergic and alpha-adrenergic mechanisms stimulate rat growth hormone release via growth hormone releasing factor. Endocrinology 1984; 114: 1950–2
   PubMed Web of Science ®Google Scholar
• Katakami H, Kato Y, Matsushita N, Imura H. Effects of neonatal treatment with monosodium glutamate on growth hormone release induced by clonidine and prostaglandin E, in conscious male rats. Neuroendocrinology 1984; 38: 1–5
   PubMed Web of Science ®Google Scholar
• Laron Z, Topper E, Gil-Ad I. Oral clonidine – a simple, safe and effective test for growth hormone secretion. Pediatr Adolesc Endorcrinol 1983; 12: 103–14
   Google Scholar
• Keller E, Sorger D, Willergodt H. Clonidine (Haemiton) as a reliable stimulus of growth hormone secretion in patients with short stature. Exp Clin Endocrinol 1983; 81: 315–19
   PubMedGoogle Scholar
• Pintor C, Cella C G, Loche S, Puggioni R, Corda R, Locatelli V, Muller E E. Clonidine treatment for short stature. Lancet 1987; 8544: 1226–7
   Google Scholar
• Matussek N, Ackenheil M, Hippius H, Muller F, Schröder H-Th, Schultes H, Wailewski B. Effects of clonidine on growth hormone release in psychiatric patients and controls. Psychiatr Res 1980; 2: 25–36
   PubMed Web of Science ®Google Scholar
• Checkley S A, Slade A P, Shur E. Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 1981; 138: 51–5
   PubMed Web of Science ®Google Scholar
• Charney D S, Heninger G R, Sternberg D E, Hafstad K M, Giddings S, Landis D H. Adrenergic receptor sensitivity in depression Effects of clonidine in depressed patients and healthy subjects. Arch Gen Psychiatry 1982; 39: 290–4
   PubMed Web of Science ®Google Scholar
• Siever L J, Uhde T W, Silberman E K, Jimerson E D, Aloi J A, Post R M, Murphy D I. Growth hormone response to clonidine as a probe of nor-adrenergic receptor responsiveness in affective disorder patients and controls. Psychiatr Res 1982; 6: 171–83
   PubMed Web of Science ®Google Scholar
• Assneau M, Scheyvaerts M, Doumont A, Poirrier R, Legros J-L, Franck G. Concurrent use of REM latency, dexamethasone suppression, clonidine and apomorphine tests as biological markers of endogenous depression: A pilot study. Psychiatr Res 1984; 12: 261–72
   PubMed Web of Science ®Google Scholar
• Glass I B, Checkley S A, Shur E, Dawling S. The effect of desipramine upon central adrenergic function in depressed patients. Br J Psychiatry 1982; 141: 372–6
   PubMed Web of Science ®Google Scholar
• Corn T H, Thompson C, Checkley S A. Effects of desipramine treatment upon central adrenoceptor function in normal subjects. BR J Psychiatry 1984; 145: 139–45
   PubMed Web of Science ®Google Scholar
• Catalano M, Bellod L, Lucca A, Brambilla F. Lithium and alpha2-adrenergic receptors: Effects of lithium ion on clonidine-induced growth hormone release. Neuroendocrinol Lett 1984; 6: 61–6
   Web of Science ®Google Scholar
• Matussek N. Biological aspects of depression. Psychopathology 1986; 19: 66–71, supp. 2
   PubMed Web of Science ®Google Scholar
• Matussek N, Ackenheil M, Herz H. The dependence of the clonidine growth hormone test on alcohol drinking habits and the menstrual cycle. Psychoneuroendocrinology 1984; 9: 173–77
   PubMed Web of Science ®Google Scholar
• Jansson J-O, Eriksson E, Eden S, Modigh K. Effects of gonadectomy and testosterone replacement on growth hormone responses to alpha2-adrenoceptor stimulation in the male rat. Psychoneuroendocrinology 1982; 7: 245–8
   PubMed Web of Science ®Google Scholar
• Eriksson E, Modigh K. Depression, alpha2-receptors and sex hormones: Neuroendocrine studies in rat. Frontiers in Biochemical and Pharmacological Research in Depression. Adv Biochem Psychopharmacol, E Usdin, et al. Raven Press, New York 1984; 39: 161–78
   Google Scholar
• Eriksson E, Jansson J-O, Modigh K. Effects of sex steroids on growth hormone responses to clonidine and GHRH in reserpine pretreated rats. J Neural Transm 1988, in press
   PubMed Web of Science ®Google Scholar
• Tulandi T, Lal S, Guyda H. Effects of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing. J Clin Endocrinol Metab 1987; 65: 6–10
   PubMed Web of Science ®Google Scholar
• Lal S, Nair N PV, Thavundayil J X, Monks R C, Guyda H. Clonidine-induced growth hormone secretion in chronic schizophrenia. Acta Psychiatr. Scand 1983; 68: 82–8
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lampertico M, Sali L, Cavagnini F, Invitti C, Maggioni M, Candolfi C, Panerai A E, Muller E E. Clonidine stimulation in anorexia nervosa: Growth hormone, cortisol, and beta-endorphine responses. Psychiatr Res 1987; 20: 19–31
   PubMed Web of Science ®Google Scholar
• Brambilla F, Lampertico M, Panerai A E, Sali L, Salerno F, Muller E E. Effect of clonidine on the secretion of anterior pituitary hormones in heroin addicts and normal volunteers. Psychiatr Res 1984; 13: 295–304
   PubMed Web of Science ®Google Scholar
• Uhde T W, Vittone B J, Siever L J, Kave W H, Post R M. Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry 1986; 21: 1081–5
   PubMed Web of Science ®Google Scholar
• Charney D S, Heninger G R. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1986; 48: 1042–54
   Google Scholar
• Siever L J, Insel T R, Jimerson D C, Lake C R, Uhde T W, Aloi J, Murphy D L. Growth hormone response to clonidine in obsessive-compulsive patients. Br J Psychiatry 1983; 142: 184–7
   PubMed Web of Science ®Google Scholar
• Barbieri C, Ferrari C, Caldara R, Curtarelli G. Growth hormone secretion in hypertensive patients: Evidence for a derangement in central adrenergic function. Clin Sci 1980; 58: 135–8
   PubMed Web of Science ®Google Scholar
• Eriksson E, Dellborg M, Söderpalm B, Carlsson M, Nilsson C. The growth hormone responses to clonidine and to GRF in spontaneously hypertensive rats: Neuroendocrine evidence for an enhanced responsiveness of brain alpha2-adrenoceptors in genetical hypertension. Life Sci 1986; 39: 2103–9
   PubMed Web of Science ®Google Scholar
• Lechin F, van der Dus B, Jackubowicz D, Camero R E, Lechin S, Villa S, Reinfeld B, Lechin M E. Role of stress in the exacerbation of chronic illness: Effects of clonidine administration on blood pressure and plasma norepinephrine, cortisol, growth hormone and prolactin concentrations. Psychoneuroendocrinology 1987; 12: 117–29
   PubMed Web of Science ®Google Scholar
• Hunt R D, Cohen D J, Anderson G, Clark L. Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: Growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity. Life Sci 1984; 35: 885–7
   PubMed Web of Science ®Google Scholar
• Siever L J, Tamminga C, Pert A. Increased growth hormone response to clonidine in 6-hydroxydopamine-treated rats. Psychopharmacology 1987; 91: 342–4
   PubMed Web of Science ®Google Scholar
• Heninger G K, Charney D S. Mechanisms of action of antidepressant treatments: Implications for the etiology and treatment of depressive disorders. Psychopharmacology. The Third Generation of Progress, H Y Meltzer. Raven Press, New York 1987; 535–44
   Google Scholar
• Söderpalm B, Andersson L, Carlsson M, Modigh K, Eriksson E. Serotonergic influence on the growth hormone response to clonidine in rat. J Neural Transm 1987; 69: 105–16
   PubMed Web of Science ®Google Scholar
• Arnold M A, Fernstrom J D. Administration of antisomatostatin serum to rats reverses the inhibition of pulsatile growth hormone secretion produced by injection of metergoline but not yohimbine. Neuroendocrinology 1980; 31: 194–9
   PubMed Web of Science ®Google Scholar
• Delitala G, Maioloi M, Pacifico A, Brianda S, Palerom M, Manelli M. Cholinergic receptor control mechanisms for I-DOPA, apomorphine, and clonidine-induced growth hormone secretion in man. J Clin Endocrinol Metab 1983; 57: 1145–9
   PubMed Web of Science ®Google Scholar
• Casanueva F F, Villanueva L, Cabranes J A, Cabezas-Cerrato J, Fernandez-Cruz A. Cholinergic mediation of growth hormone secretion elicited by arginine, clonidine, and physical exercise in man. J Clin Endocrinol Metab 1984; 59: 526–30
   PubMed Web of Science ®Google Scholar
• Massara F, Ghigo E, Goffi S, Molinatti G M, Muller E E, Camanni F. Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J Clin Endocrinol Metabol 1984; 59: 1025–6
   PubMed Web of Science ®Google Scholar
• Locatelli V, Torsello A, Radaelli M, Ghigo E, Massara F, Muller E E. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-relasing hormone in the rat: evidence for mediation by somatostatin. J Endocrinol 1986; 111: 271–8
   PubMed Web of Science ®Google Scholar
• Delitala G, Palermo M, Ross R, Coy D, Besser M, Grossman A. Dopaminergic and cholinergic influence on the growth hormone response to growth hormone-releasing hormone in man. Neuroendocrinology 1987; 45: 243–7
   PubMed Web of Science ®Google Scholar
• Vance M L, Kaiser D L, Frohman L A, Rivier J, Vale W W, Thorner M O. Role of dopamine in the regulation of growth hormone secretion: Dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. J Clin Endocrin of Metab 1987; 64: 1136–41
   PubMed Web of Science ®Google Scholar
• Krishnan K RR, Manepalli A, Rayasam K, Melville M L, Daughtry G, Rivier J, Vale W, Thorner M O, Nemeroff C B. Somatotroph response to GHRH in depression. 15th Collegium Internationale Neuro-Psychopharmacologicum Congress. San Juan, Puerto Rico Dec., 1986; 206, Abstract.
   Google Scholar
• Laakmann G, Neuhauser H, Hinz A, Neulinger E, Wittman M. Stimulation of growth hormone, prolactin, and cortisol by GHRH and DMI in depressed patients. Pharmacopsychiatria 1986; 19: 235–6
   Google Scholar
• Risch S, Janowsky D, Judd L, Gillin J, Ehlers C. Attenuated growth hormone response to human growth hormone releasing factor in depressed subjects vs. matched controls. 15th Collegium International Neuro-Psychopharmacologicum Congress. San Juan, Puerto Rico Dec., 1986; 197, Abstract.
   Google Scholar
• Eriksson E, Balldin J, Lindstedt G, Modigh K. Growth hormone responses to the alpha2-adrenoceptor agonist guanfacine and to growth hormone releasing hormone in depressed patients and controls. Psychol Res 1988, in press
   Google Scholar
• Corn T H, Hale A S, Thompson C, Bridges P K, Checkley S A. A comparison of the growth hormone responses to clonidine and apomorphine in same patients with endogenous depression. Br J Psychiatry 1984; 144: 636–9
   PubMed Web of Science ®Google Scholar
• Jimerson D C. Role of dopamine mechanisms in the affective disorders. Psychopharmacology: The Third Generation of Progress, H Y Meltzer. Raven Press, New York 1987; 505–2
   Google Scholar
• Sachar E J, Finkelstein J, Hellman L. Growth hormone responses in depressive illness. I. Response to insulin tolerance test. Arch Gen Psychiatry 1971; 25: 263–9
   Web of Science ®Google Scholar
• Laakrnann G. Beeinflussung der Hypophysenvorderlappen-Hormon-Sekretion durch Antidepres-siva bei gesunden Probanden, neurotisch und endogen depressiven Patienten. Nervenarzt 1980; 51: 725–32
   PubMedGoogle Scholar
• Martin J B, Brazeau P, Tannenbaum G S, Willoughby J O, Epelbaum J, Terry L C, Durand D. Neuroendocrine organization of growth hormone regulation, S Reichlin, R J Baldessarini, J B Martin. Raven Press, New York 1987; 329–35
   Google Scholar
• Laakmann G, Zygan K, Schoen H-W, Weiss A, Wittmann M, Meissner R, Blaschke D. Effect of receptor blockers (methysergide, propranolol, phentolamine, yohimbine and prazosin) on desipramine-induced pituitary hormone stimulation in humans – I. Growth hormone. Psychoneuroendocrinology 1986; 11: 447–61
   PubMed Web of Science ®Google Scholar
• Eriksson E, Eden S, Modigh K. Importance of norepinephrine alpha-receptor activation for morphine-induced rat growth hormone secretion. Neuroendocrinology 1981; 33: 91–6
   PubMed Web of Science ®Google Scholar
• Brown J, Doxey J C, Handley S. Effects of alpha-adrenoceptor agonists and antagonists and of anti-depressant drugs on pre- and postsynaptic alpha-adrenoceptors. Eur J Pharacol 1980; 67: 33–40
   Google Scholar
• Scholtysik G, Jerie P, Picard C W. Guanfacine. Pharmacology of antihypertensive drugs, A Scriabine. Raven Press, New York 1980; 79–98
   Google Scholar
• Hoefke W. Clonidine. Pharmacology of antihypertensive drugs, A Scriabine. Raven Press, New York 1980; 55–78
   Google Scholar
• Isaac L. Brain sites for the antihypertensive action of clonidine. Psychopharmacology of clonidine, H Lal, S Fielding. Alan R Liss Inc, New York 1981; 29–39
   Google Scholar
• Carlsson A. Dopamine receptor agonists: Intrinsic activity vs. state of receptor. J Neural Transm 1983; 67: 309–15
   Google Scholar
• Nutt D J. Increased central alpha2-adrenoceptor sensitivity in panic disorder. Psychopharmacology 1986; 90: 268–9
   PubMed Web of Science ®Google Scholar